33604-87-4

Basic information

• Product Name: 1H-Benzimidazole,2-chloro-4-methoxy-1-methyl-(9CI)
• Synonyms: 1H-Benzimidazole,2-chloro-4-methoxy-1-methyl-(9CI)
• CAS NO: 33604-87-4
• Molecular Formula: C9H9ClN2O
• Molecular Weight: 196.63356
• Product Categories: BENZIMIDAZOLE
• Mol File: 33604-87-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-Benzimidazole,2-chloro-4-methoxy-1-methyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Benzimidazole,2-chloro-4-methoxy-1-methyl-(9CI)(33604-87-4)
• EPA Substance Registry System: 1H-Benzimidazole,2-chloro-4-methoxy-1-methyl-(9CI)(33604-87-4)

Safety Data

• Hazardous Substances Data: 33604-87-4(Hazardous Substances Data)

Usage

General Description

1H-Benzimidazole, 2-chloro-4-methoxy-1-methyl-(9CI) is a chemical compound with the molecular formula C10H10ClN2O. It is a derivative of benzimidazole, which is a bicyclic organic compound. The compound is characterized by the presence of a chlorine atom at the 2 position, a methoxy group at the 4 position, and a methyl group at the 1 position on the benzimidazole ring. This chemical may have potential applications in the field of medicinal chemistry due to its structural features, which could make it suitable as a pharmacophore for drug development. Additionally, it may also have uses in organic synthesis and as a starting material for the production of other compounds.

Upstream product

• 1143575-95-4 (3-methoxy-2-nitrophenyl)-(methyl)amine 
• 158461-29-1 tert-butyl N-(2-nitro-3-methoxyphenyl)carbamate 
• 4920-80-3 3-methoxy-2-nitrobenzoic acid 
• 1143575-96-5 4-methoxy-1-methyl-1,3-dihydrobenzimidazol-2-one 
• 1143575-94-3 tert-butyl (3-methoxy-2-nitrophenyl)-(methyl)carbamate 
• 106837-96-1 (3-methoxy-2-nitrophenyl)-methylamine 
• 177477-60-0 3-methoxy-N₁-methylbenzene-1,2-diamine 

Relevant articles and documents

-

-

DRUG COMBINATIONS CONTAINING PDE4 INHIBITORS AND NSAIDS

The present invention relates to new drug combinations which contain in addition to one or more PDE4-inhibitors at least one NSAID (=non-steroidal anti-inflammatory drug) (2), processes for preparing them and their use in treating in particular respiratory complaints such as for example COPD, chronic sinusitis and asthma. The invention particularly relates to those drug combinations which, in addition to one or more, preferably one PDE4 inhibitor of general formula 1 wherein X is SO or SO2, but preferably SO, and wherein R3 denotes an optionally substituted, mono- or bicyclic, unsaturated, partly saturated or saturated heterocyclic group or an optionally substituted, mono- or bicyclic heteroaryl and wherein R1 and R2 have the meanings given in claim 1, contain at least one NSAID (2), the preparation thereof and the use thereof for the treatment of respiratory complaints.